|
ESCMID/ECMM guidelines recommend the use of [[voriconazole]] for the treatment of invasive ''T. asahii'' infections.[{{Cite journal |last1=Arendrup |first1=M.C. |last2=Boekhout |first2=T. |last3=Akova |first3=M. |last4=Meis |first4=J.F. |last5=Cornely |first5=O.A. |last6=Lortholary |first6=O. |date=Apr 2014 |title=ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections |journal=Clinical Microbiology and Infection |language=en |volume=20 |pages=76–98 |doi=10.1111/1469-0691.12360|pmid=24102785 |doi-access=free |hdl=20.500.11755/17cd1afe-00d4-46aa-bfb2-1259174c5ba6 |hdl-access=free }}] Patients have also been treated with amphotericin B and triazole therapy. |
|
ESCMID/ECMM guidelines recommend the use of [[voriconazole]] for the treatment of invasive ''T. asahii'' infections.[{{Cite journal |last1=Arendrup |first1=M.C. |last2=Boekhout |first2=T. |last3=Akova |first3=M. |last4=Meis |first4=J.F. |last5=Cornely |first5=O.A. |last6=Lortholary |first6=O. |date=Apr 2014 |title=ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections |journal=Clinical Microbiology and Infection |language=en |volume=20 |pages=76–98 |doi=10.1111/1469-0691.12360|pmid=24102785 |doi-access=free |hdl=20.500.11755/17cd1afe-00d4-46aa-bfb2-1259174c5ba6 |hdl-access=free }}] Patients have also been treated with [[amphotericin B]] and triazole therapy. |
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
